Rosalyn George, MD
Dermatology · Wilmington, NCNPI 1639391931
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 91.7% of it on its own, with 26 other manufacturers making up the rest. Among dermatology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 787 payments — averaging $439.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$317K
- Galderma Laboratories, L.p.$18K
- UCB, Inc.$7K
- Merz North America, Inc.$1K
- Johnson & Johnson$801
- Novartis$337
- plus $2K from 21 others
Across 553 payments — averaging $11,214 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$3.6M
- Amgen$767K
- UCB SA$607K
- Eli Lilly$403K
- Janssen Research & Development, LLC$267K
- E.r. Squibb & Sons, L.L.C.$177K
- plus $419K from 8 others
What the payments were for
- Consulting fees$161,35047%
- Speaking & faculty fees$121,93335%
- Travel & lodging$46,51613%
- Food & beverage$15,9105%
- Education$2910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 547 | $317,120 |
| Galderma Laboratories, L.p. | 46 | $17,779 |
| UCB, Inc. | 16 | $6,842 |
| Merz North America, Inc. | 14 | $1,258 |
| Johnson & Johnson | 50 | $801 |
| Novartis | 18 | $337 |
| Regeneron Healthcare Solutions, Inc. | 10 | $240 |
| Lilly USA, LLC | 16 | $226 |
| Almirall LLC | 5 | $216 |
| Sun Pharmaceutical Industries Inc. | 11 | $203 |
| Sanofi | 4 | $182 |
| Pfizer | 14 | $156 |
| E.r. Squibb & Sons, L.L.C. | 7 | $110 |
| Revance Therapeutics, Inc. | 1 | $68 |
| Endo Pharmaceuticals Inc. | 1 | $68 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $57 |
| Biofrontera Inc. | 3 | $54 |
| Dermavant Sciences, Inc. | 3 | $49 |
| Organon | 8 | $40 |
| Prugen, Inc. Pharmaceuticals | 3 | $37 |
| Incyte Corporation | 2 | $31 |
| LEO Pharma Inc. | 2 | $28 |
| VYNE Pharmaceuticals Inc. | 1 | $22 |
| EPI Health, LLC | 1 | $21 |
| Dermira, Inc. | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| Mayne Pharma Commercial LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$345,999 in reported general payments places this provider in the 95th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 16 | $121,600 |
| Dupixent PenDupilumab | 13 | $47,182 |
| Clobetasol Propionate | 59 | $3,674 |
| Tretinoin | 41 | $3,265 |
| Doxycycline Hyclate | 98 | $2,731 |
| Mycophenolate Mofetil | 17 | $2,090 |
| Metronidazole | 29 | $1,967 |
| Triamcinolone Acetonide | 125 | $1,326 |
| ValacyclovirValacyclovir Hcl | 105 | $1,275 |
| Fluorouracil | 19 | $1,049 |
| Minoxidil | 59 | $870 |
| Betamethasone Dipropionate | 17 | $839 |
| Ketoconazole | 54 | $784 |
| Fluocinonide | 16 | $597 |
| Mupirocin | 37 | $337 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Wilmington
- Laura TannerWilmington$54K
- Aron GewirtzmanWilmington$17K
- Jonathan CraneWilmington$14K
- Steven FeldmanWinston Salem$3.4M
- Nicole SeminaraHuntersville$1.4M
- Andrew LeeElkin$702K
- Christopher SayedChapel Hill$690K
- William HooverConcord$594K
- Patrick McElgunnCharlotte$565K
- George MagelHickory$554K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.